StockData
BETRFOTCPharmaceutical PreparationsFiscal year ends January 31

BetterLife Pharma Inc.

Financials through fiscal 2026, year ended Jan 31, 2026Last filing: 20-F on Jun 1, 2026
$0.15−0.01 (-3.71%)

Close on Oct 19, 2026

Market cap
$22.36M
P/E (TTM)
–
Dividend yield
–

BetterLife Pharma Inc. revenue by segment

No segment breakdown reported

BetterLife Pharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.